Guangzhou Xilan Flower Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Xilan Flower Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CHRMJERN. The owner is based in Guangzhou.

Shatou Vil, Shatou St, Panyu Dist

Guangzhou 511400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CHRMJERN
CHRMJERN
Registered 2023

Trademark Classifications

Guangzhou Xilan Flower Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou Xilan Flower Trading Co., Ltd. have?

Guangzhou Xilan Flower Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Xilan Flower Trading Co., Ltd. file in?

Guangzhou Xilan Flower Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Guangzhou Xilan Flower Trading Co., Ltd.'s most well-known trademarks?

Guangzhou Xilan Flower Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as CHRMJERN. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Xilan Flower Trading Co., Ltd.'s trademark registration success rate?

Guangzhou Xilan Flower Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.